121
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Subgroup analysis of telehealthcare for patients with chronic obstructive pulmonary disease: the cluster-randomized Danish Telecare North Trial

, , &
Pages 391-401 | Published online: 07 Jul 2017

References

  • de ToledoPJiménezSdel PozoFRocaJAlonsoAHernandezCTelemedicine experience for chronic care in COPDIEEE Trans Inf Technol Biomed200610356757316871726
  • HaesumLKSoerensenNDinesenBCost-utility analysis of a telerehabilitation program: a case study of COPD patientsTelemed J E Health201218968869223020647
  • KoffPBJonesRHCashmanJMVoelkelNFVandivierRWProactive integrated care improves quality of life in patients with COPDEur Respir J20093351031103819129289
  • ParéGPoba-NzaouPSicotteCComparing the costs of home telemonitoring and usual care of chronic obstructive pulmonary disease patients: a randomized controlled trialEur Res Telemed2013223547
  • ParéGSicotteCSt-JulesDGauthierRCost-minimization analysis of a telehomecare program for patients with chronic obstructive pulmonary diseaseTelemed J E Health200612211412116620165
  • VitaccaMBianchiLGuerraATele-assistance in chronic respiratory failure patients: a randomised clinical trialEur Respir J200933241141818799512
  • McDowellJEMcCleanSFitzGibbonFTateSA randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPDJ Telemed Telecare2015212808725586812
  • StoddartAvan der PolMPinnockHTelemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trialJ Telemed Telecare201521210811825586810
  • SculpherMReflecting heterogeneity in patient benefits: the role of subgroup analysis with comparative effectivenessValue Health201013Suppl 1S18S2120618790
  • WillanARBriggsAHHochJSRegression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness dataHealth Econ200413546147515127426
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)2016Global Strategy for the Diagnosis, Management and Prevention of COPD -2016 Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/Last accessed June 22, 2017
  • ChapmanKRManninoDMSorianoJBEpidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J200627118820716387952
  • McLeanSNurmatovULiuJLPagliariCCarJSheikhATelehealthcare for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20117152
  • UdsenFWLilholtPHHejlesenOEhlersLCost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish “TeleCare North” cluster-randomized trialBMJ Open201775e014616
  • HoferFAchelrodDStargardtTCost-utility analysis of telemonitoring interventions for patients with chronic obstructive pulmonary disease (COPD) in GermanyAppl Health Econ Health Policy201614669170127475635
  • UdsenFWLilholtPHHejlesenOEhlersLHEffectiveness and cost-effectiveness of telehealthcare for chronic obstructive pulmonary disease: study protocol for a cluster randomized controlled trialTrials20141517824886225
  • The Danish Health Data BoardLandspatientregisteret - Borgernes kontakter til sygehusene [The National Patient Register] Available from: http://www.esundhed.dk/sundhedsregistre/LPR/Sider/LPR.aspxLast accessed June 17, 2017 Danish
  • The Danish Health Data BoardDokumentation af registrene [The National Health Insurance Service Register] Available from: http://www.esundhed.dk/dokumentation/Registre/Sider/Register.aspxLast accessed June 17, 2017 Danish
  • The Danish Health Data BoardLægemiddelstatistik - Forbrug af lægemidler i Danmark [The Register of Medicinal Product Statistics] Available from: http://esundhed.dk/sundhedsregistre/LSR/Sider/LSR.aspxLast accessed June 17, 2017 Danish
  • Wittrup-JensenKULauridsenJGudexCPedersenKMGeneration of a Danish TTO value set for EQ-5D health statesScand J Public Health200937545946619411320
  • FariaRGomesMEpsteinDWhiteIRA guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trialsPharmacoeconomics201432121157117025069632
  • SculpherMSubgroups and heterogeneity in cost-effectiveness analysisPharmacoeconomics200826979980618767899
  • UdsenFHejlesenOEhlersLA systematic review of the cost and cost-effectiveness of telehealthcare to patients suffering from chronic obstructive pulmonary diseaseJ Telemed Telecare201420421222024803277
  • Jódar-SánchezFOrtegaFParraCCost-utility analysis of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapyJ Telemed Telecare201420630731625052387
  • LamotheLFortinJPLabbéFGagnonMPMessikhDImpacts of telehomecare on patients, providers, and organizationsTelemed J E Health200612336336916796505
  • SkinnerJCauses and consequences of regional variations in health CarePaulyMVMcguireTGBarrosPPHandbook of Health Economics2OxfordNew York20124593
  • KrumholzHMVariations in health care, patient preferences, and high-quality decision makingJAMA2013310215115223839747
  • WoottonRTwenty years of telemedicine in chronic disease management—an evidence synthesisJ Telemed Telecare201218421122022674020
  • GoldsteinRSO’HoskiSTelemedicine in COPD: time to pauseChest2014145594594924798834